A startup widely known as “ChatGPT for doctors” raised a new funding round that values the company at $12 billion.
OpenEvidence, based in Cambridge, Massachusetts, closed a $250 million financing, led by Thrive Capital and DST, the company told CNBC. The startup first raised outside capital in February, when it reeled in $75 million from Sequoia at a $1 billion valuation, before its value jumped to $6 billion in October.
In less than a year, OpenEvidence has raised $700 million from investors including Google’s
venture arm, Nvidia
, Kleiner Perkins, David Sacks’ Craft Ventures and Mayo Clinic.
